157 related articles for article (PubMed ID: 16403096)
1. Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris.
Capon F; Bharkhada J; Cochrane NE; Mortimer NJ; Setterfield JF; Reynaert S; Black MM; Vaughan RW; Trembath RC; Harman KE
Br J Dermatol; 2006 Jan; 154(1):67-71. PubMed ID: 16403096
[TBL] [Abstract][Full Text] [Related]
2. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus.
Loiseau P; Lecleach L; Prost C; Lepage V; Busson M; Bastuji-Garin S; Roujeau JC; Charron D
J Autoimmun; 2000 Aug; 15(1):67-73. PubMed ID: 10936030
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of human Dsg3-specific B cells isolated by flow cytometry from the peripheral blood of patients with pemphigus vulgaris.
Yamagami J; Takahashi H; Ota T; Amagai M
J Dermatol Sci; 2008 Nov; 52(2):98-107. PubMed ID: 18586466
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus.
Miyagawa S; Amagai M; Niizeki H; Yamashina Y; Kaneshige T; Nishikawa T; Shirai T; Inoko H
Tissue Antigens; 1999 Oct; 54(4):333-40. PubMed ID: 10551416
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of desmoglein 3 (DSG3) sequence variants in patients with pemphigus vulgaris.
Capon F; Boulding H; Quaranta M; Mortimer NJ; Setterfield JF; Black MM; Trembath RC; Harman KE
Br J Dermatol; 2009 Dec; 161(6):1403-5. PubMed ID: 19678820
[No Abstract] [Full Text] [Related]
8. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
[TBL] [Abstract][Full Text] [Related]
9. [PCR determination of an association between class II HLA and pemphigus vulgaris].
Glorio RR; Rodríguez Costa G; Haas R; Larriba J; Fainboim L; Woscoff A
Medicina (B Aires); 1999; 59(1):28-32. PubMed ID: 10349115
[TBL] [Abstract][Full Text] [Related]
10. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
11. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
[TBL] [Abstract][Full Text] [Related]
12. Role of intramolecular epitope spreading in pemphigus vulgaris.
Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
[TBL] [Abstract][Full Text] [Related]
13. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
[TBL] [Abstract][Full Text] [Related]
15. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
[TBL] [Abstract][Full Text] [Related]
17. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease.
Rizzo C; Fotino M; Zhang Y; Chow S; Spizuoco A; Sinha AA
Clin Exp Dermatol; 2005 Sep; 30(5):535-40. PubMed ID: 16045688
[TBL] [Abstract][Full Text] [Related]
18. Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris.
Dhandha MM; Seiffert-Sinha K; Sinha AA
Autoimmunity; 2012 Nov; 45(7):516-26. PubMed ID: 22779708
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicine.
Mahmoudi H; Ebrahimi E; Daneshpazhooh M; Balighi K; Mirzazadeh A; Elikaei Behjati S; Tavakolpour S
Int J Immunogenet; 2020 Feb; 47(1):41-49. PubMed ID: 31342641
[TBL] [Abstract][Full Text] [Related]
20. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
